Medicare Enrolled

Dr. James Vestal, MD

Urology Physician · Arlington, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
5005 S COOPER ST STE 250, Arlington, TX 76017
8663678768
In practice since 2005 (20 years)
NPI: 1770579161 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vestal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vestal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vestal

Dr. James Vestal is an urology physician in Arlington, TX, with 20 years in practice. Based on federal Medicare data, Dr. Vestal performed 8,759 Medicare services across 1,949 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vestal received a total of $314,401 from 58 pharmaceutical and/or device companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vestal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in TX$ $314,401 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,759
Medicare services
Top 11% in TX for urology physician
1,949
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~438 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,220$18$53
BCG treatment for bladder cancer1,890$2$9
Leuprolide injectable, camcevi, 1 mg1,344$64$195
Office visit, established patient (30-39 min)706$87$278
Chronic care management, first 20 min/month301$48$122
Blood draw (venipuncture)274$6$12
PSA test (prostate cancer screening)208$18$41
Urinalysis, manual201$3$8
Automated urinalysis168$2$5
Complete blood count (CBC), automated154$6$14
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month146$47$122
Diagnostic exam of bladder and urethra using an endoscope116$175$532
Bladder ultrasound after voiding115$8$23
Leuprolide acetate (for depot suspension), 7.5 mg108$129$374
Testosterone (hormone) level, total105$25$57
Comprehensive metabolic blood panel88$10$23
Instillation of anti-cancer drug into bladder82$68$201
Office visit, established patient (20-29 min)70$65$201
Basic metabolic blood panel67$8$19
Drug injection, under skin or into muscle62$11$32
Office visit, established patient, complex (40-54 min)60$129$373
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle50$26$78
Chronic care management, additional 20 min/month50$37$120
Ceftriaxone antibiotic injection46$0$1
New patient office visit (45-59 min)26$130$361
Insertion of stent in ureter using an endoscope22$95$982
Simple bladder irrigation and/or instillation15$58$176
Destruction and/or removal of large growth of bladder using an endoscope13$286$845
Biopsy of prostate gland13$176$516
Ultrasound scan of pelvic region through rectum13$100$299
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional13$18$53
Initial hospital admission, high complexity13$135$391
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
28.8% medium
71.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$314,401
Total received (2018-2024)
Avg $44,914/year across 7 years
Top 2% in TX for urology physician
58
Companies
771
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$267,190 (85.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$36,297 (11.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,713 (3.4%)
Scientific / Research
Research funding and grants
$201 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$37,384
2023
$25,871
2022
$44,856
2021
$27,895
2020
$16,021
2019
$60,402
2018
$101,974

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$150,873
Janssen Scientific Affairs, LLC
$60,442
GENZYME CORPORATION
$44,486
Bayer Healthcare Pharmaceuticals Inc.
$11,976
Bayer HealthCare Pharmaceuticals Inc.
$11,776
Blue Earth Diagnostics Limited
$8,227
AstraZeneca Pharmaceuticals LP
$5,697
Verity Pharmaceuticals Inc.
$3,702
Dendreon Pharmaceuticals LLC
$3,549
Clovis Oncology, Inc.
$3,279
Ferring Pharmaceuticals Inc.
$2,128
Boston Scientific Corporation
$1,063
HealthTronics Mobile Solutions, LLC
$959
UROGEN PHARMA, INC.
$746
Astellas Pharma US Inc
$612
TOLMAR Pharmaceuticals, Inc.
$548
Sun Pharmaceutical Industries Inc.
$323
Sumitomo Pharma America, Inc.
$299
Palette Life Sciences, Inc.
$293
Olympus America Inc.
$260
AbbVie Inc.
$252
Myovant Sciences Inc.
$237
Johnson & Johnson Health Care Systems Inc.
$227
Merck Sharp & Dohme LLC
$170
Endocare, Inc.
$162
Merck Sharp & Dohme Corporation
$152
NeoTract Inc.
$152
Axonics, Inc.
$142
Agiliti Surgical, Inc.
$131
Amgen Inc.
$131
Novartis Pharmaceuticals Corporation
$124
BOSTON SCIENTIFIC CORPORATION
$123
Janssen Products, LP
$100
PROCEPT BioRobotics Corporation
$94
AbbVie, Inc.
$91
ABBVIE INC.
$90
Coloplast Corp
$83
Myriad Genetic Laboratories, Inc.
$75
Ambu Inc.
$68
Progenics Pharmaceuticals, Inc.
$62
Aesculap, Inc.
$57
Tolmar, Inc.
$50
SANOFI-AVENTIS U.S. LLC
$48
Innovation Technologies Inc
$46
UroGen Pharma, Inc.
$42
Mission Pharmacal Company
$36
Baxter Healthcare
$34
ACCORD HEALTHCARE, INC.
$31
Covidien LP
$24
Retrophin, Inc.
$23
Cook Medical LLC
$17
MENARINI SILICON BIOSYSTEMS, INC.
$16
PROGENICS PHARMACEUTICALS, INC.
$16
Allergan Inc.
$13
UroViu Corporation
$13
Endo Pharmaceuticals Inc.
$12
PFIZER INC.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 81.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BRACANALYSIS CDX · Bulkamid · CAIMAN VESSEL SEALERS · CAMCEVI · Cellsearch · DARZALEX · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · FIRMAGON · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENERAL BPH · IMFINZI · IRRISEPT · Isiris aStent Removal Device · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · POSLUMA · PROLARIS · PROSTATE CANCER - DISEASE · PROVENGE · PYLARIFY · Prolaris · RESONANCE · RUBRACA · Rubraca · SPACEOAR · STELARA · SUTENT · TAXOTERE · TISSEEL · Trelstar · Truqap · URIBEL TABS · Uribel · Uro-G Flexible Cystoscope · UroLift · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iDrive · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for urology physician in TX.

Equivalent to $3,589 per 100 Medicare services performed
Looking for a urology physician in Arlington?
Compare urology physicians in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
144
Per 100K population
6.7
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vestal is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Vestal experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Vestal performed 2,220 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vestal receive payments from pharmaceutical companies?
Yes. Dr. Vestal received a total of $314,401 from 58 companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vestal's costs compare to other urology physicians in Arlington?
Dr. Vestal's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vestal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →